Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

Hims & Hers' future growth is expected from personalized solutions, with potential to expand the subscriber base by millions.

The Hims brand has primed people to view both their everyday health and the natural-aging processes as problems that can be ...

Hims & Hers Health (HIMS) stock moves a notch higher Monday morning after the company's weight-loss drug ad played during the ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

In response to complaints made publicly by the Partnership for Safe Medicine and the Obesity Society, Hims & Hers provided Yahoo Life with the following statement: This is a clear attempt by industry ...

One such company, Hims & Hers, will make that pitch to the Super Bowl’s massive audience with a commercial it released last week. However, the spot has come under heavy fire from lawmakers and patient ...

We recently published a list of 12 Best Beauty Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

Fortunately, online telehealth services like Hims and Ro have emerged, providing convenient and discreet access to ED medications and treatments. These platforms enable men to seek help without the ...

A Super Bowl ad on weight loss drugs from Hims & Hers has caught the attention of Congress. Sen. Dick Durbin (D-Ill.) and Sen. Dr. Roger Marshall (R-Kan.) sent a letter to Food and Drug ...

Telehealth company Hims & Hers is running its first Super Bowl ad and it appears to be poised to become one of the most talked about ads in recent memory. The 60 second spot is provocative and ...